1
|
Wardhani K, Levina A, Grau GER, Lay PA. Fluorescent, phosphorescent, magnetic resonance contrast and radioactive tracer labelling of extracellular vesicles. Chem Soc Rev 2024; 53:6779-6829. [PMID: 38828885 DOI: 10.1039/d2cs00238h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2024]
Abstract
This review focusses on the significance of fluorescent, phosphorescent labelling and tracking of extracellular vesicles (EVs) for unravelling their biology, pathophysiology, and potential diagnostic and therapeutic uses. Various labeling strategies, such as lipid membrane, surface protein, luminal, nucleic acid, radionuclide, quantum dot labels, and metal complex-based stains, are evaluated for visualizing and characterizing EVs. Direct labelling with fluorescent lipophilic dyes is simple but generally lacks specificity, while surface protein labelling offers selectivity but may affect EV-cell interactions. Luminal and nucleic acid labelling strategies have their own advantages and challenges. Each labelling approach has strengths and weaknesses, which require a suitable probe and technique based on research goals, but new tetranuclear polypyridylruthenium(II) complexes as phosphorescent probes have strong phosphorescence, selective staining, and stability. Future research should prioritize the design of novel fluorescent probes and labelling platforms that can significantly enhance the efficiency, accuracy, and specificity of EV labeling, while preserving their composition and functionality. It is crucial to reduce false positive signals and explore the potential of multimodal imaging techniques to gain comprehensive insights into EVs.
Collapse
Affiliation(s)
- Kartika Wardhani
- School of Chemistry, The University of Sydney, Sydney, New South Wales, 2006, Australia.
- Biochemistry and Biotechnology (B-TEK) Group, Bioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, 87545, USA
| | - Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, New South Wales, 2006, Australia.
| | - Georges E R Grau
- Sydney Nano, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Sydney Cancer Network, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Marie Bashir Institute, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Vascular Immunology Unit, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, 2006, Australia
| | - Peter A Lay
- School of Chemistry, The University of Sydney, Sydney, New South Wales, 2006, Australia.
- Sydney Nano, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Sydney Cancer Network, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Marie Bashir Institute, The University of Sydney, Sydney, New South Wales, 2006, Australia
- Sydney Analytical, The University of Sydney, Sydney, New South Wales, 2006, Australia
| |
Collapse
|
2
|
Wardhani K, Levina A, Sun B, Zou H, Grau GER, Keene FR, Collins JG, Lay PA. Tetranuclear Polypyridylruthenium(II) Complexes as Selective Nucleic Acid Stains for Flow Cytometric Analysis of Monocytic and Epithelial Lung Carcinoma Large Extracellular Vesicles. Biomolecules 2024; 14:664. [PMID: 38927067 PMCID: PMC11202172 DOI: 10.3390/biom14060664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2024] [Revised: 05/31/2024] [Accepted: 06/02/2024] [Indexed: 06/28/2024] Open
Abstract
Selective staining of extracellular vesicles (EVs) is a major challenge for diagnostic and therapeutic applications. Herein, the EV labeling properties of a new class of tetranuclear polypyridylruthenium(II) complexes, Rubb7-TNL and Rubb7-TL, as phosphorescent stains are described. These new stains have many advantages over standard stains to detect and characterize EVs, including: high specificity for EV staining versus cell staining; high phosphorescence yields; photostability; and a lack of leaching from EVs until incorporation with target cells. As an example of their utility, large EVs released from control (basal) or lipopolysaccharide (LPS)-stimulated THP-1 monocytic leukemia cells were studied as a model of immune system EVs released during bacterial infection. Key findings from EV staining combined with flow cytometry were as follows: (i) LPS-stimulated THP-1 cells generated significantly larger and more numerous large EVs, as compared with those from unstimulated cells; (ii) EVs retained native EV physical properties after staining; and (iii) the new stains selectively differentiated intact large EVs from artificial liposomes, which are models of cell membrane fragments or other lipid-containing debris, as well as distinguished two distinct subpopulations of monocytic EVs within the same experiment, as a result of biochemical differences between unstimulated and LPS-stimulated monocytes. Comparatively, the staining patterns of A549 epithelial lung carcinoma-derived EVs closely resembled those of THP-1 cell line-derived EVs, which highlighted similarities in their selective staining despite their distinct cellular origins. This is consistent with the hypothesis that these new phosphorescent stains target RNA within the EVs.
Collapse
Affiliation(s)
- Kartika Wardhani
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; (K.W.); (H.Z.)
- Biochemistry and Biotechnology (B-TEK) Group, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; (K.W.); (H.Z.)
| | - Biyun Sun
- School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, Australia;
| | - Haipei Zou
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; (K.W.); (H.Z.)
| | - Georges E. R. Grau
- Sydney Nano, The University of Sydney, Sydney, NSW 2006, Australia;
- Sydney Cancer Network, The University of Sydney, Sydney, NSW 2006, Australia
- Marie Bashir Institute, The University of Sydney, Sydney, NSW 2006, Australia
- Vascular Immunology Unit, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia
| | - F. Richard Keene
- Discipline of Chemistry, School of Physics, Chemistry, and Earth Sciences, The University of Adelaide, Adelaide, SA 5005, Australia
- Australian Institute of Tropical Health and Medicine/Centre for Molecular Therapeutics, James Cook University, Townsville, QLD 4811, Australia
| | - J. Grant Collins
- School of Science, The University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2612, Australia;
| | - Peter A. Lay
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; (K.W.); (H.Z.)
- Sydney Nano, The University of Sydney, Sydney, NSW 2006, Australia;
- Sydney Cancer Network, The University of Sydney, Sydney, NSW 2006, Australia
- Marie Bashir Institute, The University of Sydney, Sydney, NSW 2006, Australia
- Sydney Analytical, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
3
|
Levina A, Wardhani K, Stephens LJ, Werrett MV, Caporale C, Dallerba E, Blair VL, Massi M, Lay PA, Andrews PC. Neutral rhenium(I) tricarbonyl complexes with sulfur-donor ligands: anti-proliferative activity and cellular localization. Dalton Trans 2024; 53:7866-7879. [PMID: 38632950 DOI: 10.1039/d4dt00149d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/19/2024]
Abstract
Rhenium(I) tricarbonyl complexes are widely studied for their cell imaging properties and anti-cancer and anti-microbial activities, but the complexes with S-donor ligands remain relatively unexplored. A series of six fac-[Re(NN)(CO)3(SR)] complexes, where (NN) is 2,2'-bipyridyl (bipy) or 1,10-phenanthroline (phen), and RSH is a series of thiocarboxylic acid methyl esters, have been synthesized and characterized. Cellular uptake and anti-proliferative activities of these complexes in human breast cancer cell lines (MDA-MB-231 and MCF-7) were generally lower than those of the previously described fac-[Re(NN)(CO)3(OH2)]+ complexes; however, one of the complexes, fac-[Re(CO)3(phen)(SC(Ph)CH2C(O)OMe)] (3b), was active (IC50 ∼ 10 μM at 72 h treatment) in thiol-depleted MDA-MB-231 cells. Moreover, unlike fac-[Re(CO)3(phen)(OH2)]+, this complex did not lose activity in the presence of extracellular glutathione. Taken together these properties show promise for further development of 3b and its analogues as potential anti-cancer drugs for co-treatment with thiol-depleting agents. Conversely, the stable and non-toxic complex, fac-[Re(bipy)(CO)3(SC(Me)C(O)OMe)] (1a), predominantly localized in the lysosomes of MDA-MB-231 cells, as shown by live cell confocal microscopy (λex = 405 nm, λem = 470-570 nm). It is strongly localized in a subset of lysosomes (25 μM Re, 4 h treatment), as shown by co-localization with a Lysotracker dye. Longer treatment times with 1a (25 μM Re for 48 h) resulted in partial migration of the probe into the mitochondria, as shown by co-localization with a Mitotracker dye. These properties make complex 1a an attractive target for further development as an organelle probe for multimodal imaging, including phosphorescence, carbonyl tag for vibrational spectroscopy, and Re tag for X-ray fluorescence microscopy.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Kartika Wardhani
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Liam J Stephens
- School of Chemistry, Monash University, Clayton, VIC 3800, Australia.
| | - Melissa V Werrett
- School of Chemistry, Monash University, Clayton, VIC 3800, Australia.
| | - Chiara Caporale
- Department of Chemistry, Curtin University, Bentley, WA 6102, Australia
| | - Elena Dallerba
- Department of Chemistry, Curtin University, Bentley, WA 6102, Australia
| | - Victoria L Blair
- School of Chemistry, Monash University, Clayton, VIC 3800, Australia.
| | | | - Peter A Lay
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | - Philip C Andrews
- School of Chemistry, Monash University, Clayton, VIC 3800, Australia.
| |
Collapse
|
4
|
Ekanayake RSK, Streltsov VA, Best SP, Chantler CT. Using XAS to monitor radiation damage in real time and post-analysis, and investigation of systematic errors of fluorescence XAS for Cu-bound amyloid-β. J Appl Crystallogr 2024; 57:125-139. [PMID: 38322727 PMCID: PMC10840304 DOI: 10.1107/s1600576723010890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 12/20/2023] [Indexed: 02/08/2024] Open
Abstract
X-ray absorption spectroscopy (XAS) is a promising technique for determining structural information from sensitive biological samples, but high-accuracy X-ray absorption fine structure (XAFS) requires corrections of systematic errors in experimental data. Low-temperature XAS and room-temperature X-ray absorption spectro-electrochemical (XAS-EC) measurements of N-truncated amyloid-β samples were collected and corrected for systematic effects such as dead time, detector efficiencies, monochromator glitches, self-absorption, radiation damage and noise at higher wavenumber (k). A new protocol was developed using extended X-ray absorption fine structure (EXAFS) data analysis for monitoring radiation damage in real time and post-analysis. The reliability of the structural determinations and consistency were validated using the XAS measurement experimental uncertainty. The correction of detector pixel efficiencies improved the fitting χ2 by 12%. An improvement of about 2.5% of the structural fitting was obtained after dead-time corrections. Normalization allowed the elimination of 90% of the monochromator glitches. The remaining glitches were manually removed. The dispersion of spectra due to self-absorption was corrected. Standard errors of experimental measurements were propagated from pointwise variance of the spectra after systematic corrections. Calculated uncertainties were used in structural refinements for obtaining precise and reliable values of structural parameters including atomic bond lengths and thermal parameters. This has permitted hypothesis testing.
Collapse
Affiliation(s)
| | - Victor A. Streltsov
- School of Physics, University of Melbourne, Australia
- The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Australia
| | | | | |
Collapse
|
5
|
Kuramarohit S, Yaourtis AM, Nguyen A, Wood ML, Levina A, Lay PA. Anti-Migratory and Cytotoxic Activities of [Ga(8-hydroxyquinolinato) 3 ]: Roles of Endogenous Cu(II) and Drug-Induced Phenotypic Changes. Chemistry 2023; 29:e202203323. [PMID: 37385951 DOI: 10.1002/chem.202203323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 06/22/2023] [Accepted: 06/22/2023] [Indexed: 07/01/2023]
Abstract
As shown by IncuCyte Zoom imaging proliferation assays, invasive triple-negative human breast MDA-MB-231 cancer cells treated with sub-toxic doses (5.0-20 μM, 72 h) of [GaQ3 ] (Q=8-hydroxyquinolinato) caused profound morphological changes and inhibition of cell migration, which were likely due to terminal cell differentiation or similar phenotypical change. This is the first demonstration of potential use of a metal complex in differentiation anti-cancer therapy. Additionally, a trace amount of Cu(II) (0.20 μM) added to the medium dramatically increased [GaQ3 ] cytotoxicity (IC50 ~2 μM, 72 h) due to its partial dissociation and the action of the HQ ligand as a Cu(II) ionophore, as shown with electrospray mass spectrometry and fluorescence spectroscopy assays in the medium. Hence, cytotoxicity of [GaQ3 ] is strongly linked to ligand binding of essential metal ions in the medium, for example, Cu(II). Appropriate delivery mechanisms of such complexes and their ligands could enable a powerful new triple therapeutic approach for cancer chemotherapy, including cytotoxicity against primary tumour, arrest of metastases, and activation of innate and adaptive immune responses.
Collapse
Affiliation(s)
- Serene Kuramarohit
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
- University of California, Berkeley, USA
| | - Andria M Yaourtis
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Annie Nguyen
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Michelle L Wood
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
- Sydney Analytical, The University of Sydney, Sydney, NSW 2006, Australia
| | - Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Peter A Lay
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
- Sydney Analytical, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
6
|
Stephens LJ, Levina A, Trinh I, Blair VL, Werrett MV, Lay PA, Andrews PC. Ruthenium(II)-Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells. Chembiochem 2020; 21:1188-1200. [PMID: 31701616 DOI: 10.1002/cbic.201900676] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2019] [Indexed: 01/02/2023]
Abstract
RuII -arene complexes provide a versatile scaffold for novel anticancer drugs. Seven new RuII -arene-thiocarboxylato dimers were synthesized and characterized. Three of the complexes (2 a, b and 5) showed promising antiproliferative activities in MDA-MB-231 (human invasive breast cancer) cells, and were further tested in a panel of fifteen cancerous and noncancerous cell lines. Complex 5 showed moderate but remarkably selective activity in MDA-MB-231 cells (IC50 =39±4 μm Ru). Real-time proliferation studies showed that 5 induced apoptosis in MDA-MB-231 cells but had no effect in A549 (human lung cancer, epithelial) cells. By contrast, 2 a and b showed moderate antiproliferative activity, but no apoptosis, in either cell line. Selective cytotoxicity of 5 in aggressive, mesenchymal-like MDA-MB-231 cells over many common epithelial cancer cell lines (including noninvasive breast cancer MCF-7) makes it an attractive lead compound for the development of specifically antimetastatic Ru complexes with low systemic toxicity.
Collapse
Affiliation(s)
- Liam J Stephens
- School of Chemistry, Monash University, 14 Rainforest Walk, Clayton, VIC, 3800, Australia
| | - Aviva Levina
- School of Chemistry, University of Sydney, Eastern Avenue, Sydney, NSW, 2006, Australia
| | - Iman Trinh
- School of Chemistry, Monash University, 14 Rainforest Walk, Clayton, VIC, 3800, Australia
| | - Victoria L Blair
- School of Chemistry, Monash University, 14 Rainforest Walk, Clayton, VIC, 3800, Australia
| | - Melissa V Werrett
- School of Chemistry, Monash University, 14 Rainforest Walk, Clayton, VIC, 3800, Australia
| | - Peter A Lay
- School of Chemistry, University of Sydney, Eastern Avenue, Sydney, NSW, 2006, Australia
| | - Philip C Andrews
- School of Chemistry, Monash University, 14 Rainforest Walk, Clayton, VIC, 3800, Australia
| |
Collapse
|
7
|
Crans DC, Koehn JT, Petry SM, Glover CM, Wijetunga A, Kaur R, Levina A, Lay PA. Hydrophobicity may enhance membrane affinity and anti-cancer effects of Schiff base vanadium(v) catecholate complexes. Dalton Trans 2019; 48:6383-6395. [PMID: 30941380 DOI: 10.1039/c9dt00601j] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Anti-cancer activities of vanadium compounds have generated recent interest because of a combination of desirable properties for chemotherapy, i.e., strong cytotoxicities, anti-metastatic activities and relatively low systemic toxicities. Certain hydrophobic vanadium(v) Schiff base/catecholate compounds, which as shown herein, have increased stability in aqueous media and affinity for membrane interfaces. Depending on their hydrophobicity, they may be able to enter cells intact. In this manuscript, two hydrophobic V(v) catecholate substituted analogues, [VO(Hshed)(cat)] and [VO(Hshed)(dtb)], (Hshed = N-(salicylideneaminato)-N'-(2-hydroxyethyl)-1,2-ethanediamine, cat = pyrocatechol, and dtb = 3,5-di(tert-butyl)catechol and the vanadium(v) precursor [V(O)2(Hshed)]) were synthesized for their ability to interact with membranes and their anti-cancer effects. Using 51V and 1H NMR spectroscopy, the presence and location of the free ligand, H2shed, and the three V(v) complexes were examined in a model membrane microemulsion system. The stability of the three complexes was measured in aqueous solution, cell media and an inhomogeneous microemulsion system. Our results demonstrated that free ligand H2shed and the intact V(v) complexes associated with the interface but that the V-complexes hydrolyzed to some extent because oxovanadates were observed by 51V NMR spectroscopy and decreasing complex by absorption spectroscopy in cell media. When determining the effects of V(v) catecholate complexes on bone cancer cells, the strongest effects were observed with the more stable hydrophobic complex [VO(Hshed)(dtb)] that was able to best associate and penetrate the model membrane system intact. These studies are consistent with the membrane permeability studies being a good predictor for in vitro cytotoxicity assays because [VO(Hshed)(dtb)] can pass through the cellular membrane intact, which may enhance its anti-cancer activities.
Collapse
Affiliation(s)
- Debbie C Crans
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, USA.
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Kalniņa D, Levina A, Pei A, Gross KA, Lay PA. Synthesis, characterization and in vitro anti-cancer activity of vanadium-doped nanocrystalline hydroxyapatite. NEW J CHEM 2019. [DOI: 10.1039/c9nj03406d] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nanocrystalline V(v)-doped hydroxyapatite and its reduced analogue (V(v) and V(iv) mixture) show promising in vitro cytotoxicity against cultured human bone cancer cells.
Collapse
Affiliation(s)
- Daina Kalniņa
- Faculty of Materials Science and Applied Chemistry
- Riga Technical University
- Riga LV1658
- Latvia
- School of Chemistry
| | - Aviva Levina
- School of Chemistry
- University of Sydney
- Sydney
- Australia
| | - Alexander Pei
- School of Chemistry
- University of Sydney
- Sydney
- Australia
- Exchange Student from Boston University
| | - Kārlis Agris Gross
- Faculty of Materials Science and Applied Chemistry
- Riga Technical University
- Riga LV1658
- Latvia
| | - Peter A. Lay
- School of Chemistry
- University of Sydney
- Sydney
- Australia
- Sydney Analytical
| |
Collapse
|
9
|
Xu J, Gong G, Huang X, Du W. Schiff base oxovanadium complexes resist the assembly behavior of human islet amyloid polypeptide. J Inorg Biochem 2018; 186:60-69. [PMID: 29857172 DOI: 10.1016/j.jinorgbio.2018.05.006] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Revised: 05/12/2018] [Accepted: 05/16/2018] [Indexed: 10/16/2022]
Abstract
The misfolding and fibrillation of human islet amyloid polypeptide (hIAPP) is related to the pathologic process of type II diabetes mellitus (T2DM). The inhibitors of hIAPP aggregation include aromatic organic molecules, short peptides, and metal complexes. Vanadium complexes have been applied for the treatment of diabetes since the 19th century. However, the antidiabetes mechanism remains unclear. In this work, we used four Schiff base oxidovanadium(IV) complexes, namely VO(bhbb)·H2O (1, and ligand 1 H2bhbb, 2-(5-bromo-2-hydroxylbenzylideneamino) benzoic acid), VO(nhbb)·H2O (2, and lignad 2 H2nhbb, 2-(5-nitro-2-hydroxylbenzylideneamino) benzoic acid), VO(cpmp)2 (3, and ligand 3 Hcpmp, 4-chloro-2-(phenylimino) methyl) phenol), and VO(bpmp)2 (4, and ligand 4 Hbpmp, 4-bromo- 2-(phenylmino) methyl) phenol) to inhibit the fibril formation of hIAPP and reduce peptide-induced cytotoxicity. Results indicated that the four Schiff base oxidovanadium complexes effectively impeded hIAPP aggregation and disaggregated mature fibrils into monomers or oligomers. These V complexes also decreased hIAPP-induced cytotoxicity. Among the four V complexes, 1 is a promising candidate metallodrug considering its inhibitory effect, disaggregation ability, regulation of peptide-induced cytotoxicity, and binding affinity to the peptide. Our research provides a new outlook for the design of oxidovanadium complexes as effective inhibitors of hIAPP against T2DM.
Collapse
Affiliation(s)
- Jufei Xu
- Department of Chemistry, Renmin University of China, Beijing 100872, China
| | - Gehui Gong
- Department of Chemistry, Renmin University of China, Beijing 100872, China
| | - Xiangyi Huang
- Department of Chemistry, Renmin University of China, Beijing 100872, China
| | - Weihong Du
- Department of Chemistry, Renmin University of China, Beijing 100872, China.
| |
Collapse
|
10
|
Levina A, Crans DC, Lay PA. Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities. Coord Chem Rev 2017. [DOI: 10.1016/j.ccr.2017.01.002] [Citation(s) in RCA: 112] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
|
11
|
High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium. J Biol Inorg Chem 2017; 22:663-672. [PMID: 28374136 DOI: 10.1007/s00775-017-1453-4] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2017] [Accepted: 03/21/2017] [Indexed: 12/11/2022]
Abstract
Cytotoxic effects of Metvan (cis-[VIVO(OSO3)(Me2phen)2], where Me2phen = 4,7-dimethyl-1,10-phenanthroline) and its analogues with 1,10-phenanthroline (phen) and 2,2'-bipyridine (bpy) ligands in cultured human lung cancer (A549) cells have been re-investigated in conjunction with reactivity of the V(IV) complexes in neutral aerated aqueous solutions and in cell culture medium. All the V(IV) complexes underwent rapid oxidation to the corresponding V(V) species (cis-[VV(O)2L2]+), followed by release of free ligands (shown by electrospray mass spectrometry). Decomposition of V(IV) complexes in cell culture medium within minutes at 310 K was confirmed by UV-Vis and EPR spectroscopies. High cytotoxicities (low μM or sub-μM IC50 range in 72 h assays) were observed for the phen and Me2phen complexes, but they were not different from that of the corresponding free ligands, which confirmed that the original V(IV) complexes played no significant role in the observed biological activities. The cytotoxicities of the ligands were most likely due to their complexation of redox-active essential metal ions, such as Cu(II) and Fe(II), in the medium, and their increased cellular uptake, leading to oxidative stress-related cell death. These results emphasize the need to assess the stability of metal-based drugs under the conditions of biological assays, particularly when biologically active ligands, such as 1,10-phenanthroline and its derivatives, are used. These ligands have high systemic toxicities in vivo and their release in the GI tract and blood makes the complexes unsuitable for use as anti-cancer drugs.
Collapse
|
12
|
Markham J, Liang J, Levina A, Mak R, Johannessen B, Kappen P, Glover CJ, Lai B, Vogt S, Lay PA. (Pentamethylcyclopentadienato)rhodium Complexes for Delivery of the Curcumin Anticancer Drug. Eur J Inorg Chem 2017. [DOI: 10.1002/ejic.201601331] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Affiliation(s)
- Jack Markham
- School of Chemistry; The University of Sydney; 2006 NSW Australia
| | - Jun Liang
- School of Chemistry; The University of Sydney; 2006 NSW Australia
| | - Aviva Levina
- School of Chemistry; The University of Sydney; 2006 NSW Australia
| | - Rachel Mak
- School of Chemistry; The University of Sydney; 2006 NSW Australia
| | | | - Peter Kappen
- Australian Synchrotron; 800 Blackburn Rd 3168 Clayton VIC Australia
| | - Chris J. Glover
- Australian Synchrotron; 800 Blackburn Rd 3168 Clayton VIC Australia
| | - Barry Lai
- Advanced Photon Source, Building 401; Argonne National Laboratory; 9700 South Cass Ave 60439 Lemont IL USA
| | - Stefan Vogt
- Advanced Photon Source, Building 401; Argonne National Laboratory; 9700 South Cass Ave 60439 Lemont IL USA
| | - Peter A. Lay
- School of Chemistry; The University of Sydney; 2006 NSW Australia
| |
Collapse
|
13
|
Fouani L, Menezes SV, Paulson M, Richardson DR, Kovacevic Z. Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents. Pharmacol Res 2017; 115:275-287. [DOI: 10.1016/j.phrs.2016.12.001] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/14/2016] [Revised: 12/01/2016] [Accepted: 12/01/2016] [Indexed: 01/06/2023]
|
14
|
Spectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes. J Inorg Biochem 2016; 162:227-237. [DOI: 10.1016/j.jinorgbio.2016.06.015] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2015] [Revised: 06/07/2016] [Accepted: 06/14/2016] [Indexed: 11/23/2022]
|
15
|
Levina A, Pham THN, Lay PA. Binding of Chromium(III) to Transferrin Could Be Involved in Detoxification of Dietary Chromium(III) Rather than Transport of an Essential Trace Element. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201602996] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Aviva Levina
- School of Chemistry The University of Sydney Sydney NSW 2006 Australia
| | - T. H. Nguyen Pham
- School of Chemistry The University of Sydney Sydney NSW 2006 Australia
| | - Peter A. Lay
- School of Chemistry The University of Sydney Sydney NSW 2006 Australia
| |
Collapse
|
16
|
Levina A, Pham THN, Lay PA. Binding of Chromium(III) to Transferrin Could Be Involved in Detoxification of Dietary Chromium(III) Rather than Transport of an Essential Trace Element. Angew Chem Int Ed Engl 2016; 55:8104-7. [DOI: 10.1002/anie.201602996] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2016] [Indexed: 11/11/2022]
Affiliation(s)
- Aviva Levina
- School of Chemistry The University of Sydney Sydney NSW 2006 Australia
| | - T. H. Nguyen Pham
- School of Chemistry The University of Sydney Sydney NSW 2006 Australia
| | - Peter A. Lay
- School of Chemistry The University of Sydney Sydney NSW 2006 Australia
| |
Collapse
|
17
|
Gransbury GK, Kappen P, Glover CJ, Hughes JN, Levina A, Lay PA, Musgrave IF, Harris HH. Comparison of KP1019 and NAMI-A in tumour-mimetic environments. Metallomics 2016; 8:762-73. [DOI: 10.1039/c6mt00145a] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
18
|
Wu LE, Levina A, Harris HH, Cai Z, Lai B, Vogt S, James DE, Lay PA. Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes. Angew Chem Int Ed Engl 2015; 55:1742-5. [PMID: 26696553 DOI: 10.1002/anie.201509065] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2015] [Indexed: 12/31/2022]
Abstract
Chromium(III) nutritional supplements are widely consumed for their purported antidiabetic activities. X-ray fluorescence microscopy (XFM) and X-ray absorption near-edge structure (XANES) studies have now shown that non-toxic doses of [Cr3 O(OCOEt)6 (OH2 )3 ](+) (A), a prospective antidiabetic drug that undergoes similar H2 O2 induced oxidation reactions in the blood as other Cr supplements, was also oxidized to carcinogenic Cr(VI) and Cr(V) in living cells. Single adipocytes treated with A had approximately 1 μm large Cr hotspots containing Cr(III) , Cr(V) , and Cr(VI) (primarily Cr(VI) thiolates) species. These results strongly support the hypothesis that the antidiabetic activity of Cr(III) and the carcinogenicity of Cr(VI) compounds arise from similar mechanisms involving highly reactive Cr(VI) and Cr(V) intermediates, and highlight concerns over the safety of Cr(III) nutritional supplements.
Collapse
Affiliation(s)
- Lindsay E Wu
- School of Chemistry, The University of Sydney, NSW, 2006, Australia.,Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.,School of Medical Sciences, UNSW Australia, NSW, 2052, Australia
| | - Aviva Levina
- School of Chemistry, The University of Sydney, NSW, 2006, Australia
| | - Hugh H Harris
- School of Chemistry, The University of Sydney, NSW, 2006, Australia.,School of Chemistry and Physics, The University of Adelaide, SA, 5005, Australia
| | - Zhonghou Cai
- Advanced Photon Source, X-ray Science Division, Argonne National Laboratory, Argonne, IL, 60439, USA
| | - Barry Lai
- Advanced Photon Source, X-ray Science Division, Argonne National Laboratory, Argonne, IL, 60439, USA
| | - Stefan Vogt
- Advanced Photon Source, X-ray Science Division, Argonne National Laboratory, Argonne, IL, 60439, USA
| | - David E James
- Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.,Charles Perkins Centre, The University of Sydney, NSW, 2006, Australia
| | - Peter A Lay
- School of Chemistry, The University of Sydney, NSW, 2006, Australia.
| |
Collapse
|
19
|
Wu LE, Levina A, Harris HH, Cai Z, Lai B, Vogt S, James DE, Lay PA. Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201509065] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Lindsay E. Wu
- School of Chemistry; The University of Sydney; NSW 2006 Australia
- Garvan Institute of Medical Research; 384 Victoria St Darlinghurst NSW 2010 Australia
- School of Medical Sciences; UNSW Australia; NSW 2052 Australia
| | - Aviva Levina
- School of Chemistry; The University of Sydney; NSW 2006 Australia
| | - Hugh H. Harris
- School of Chemistry; The University of Sydney; NSW 2006 Australia
- School of Chemistry and Physics; The University of Adelaide; SA 5005 Australia
| | - Zhonghou Cai
- Advanced Photon Source; X-ray Science Division; Argonne National Laboratory; Argonne IL 60439 USA
| | - Barry Lai
- Advanced Photon Source; X-ray Science Division; Argonne National Laboratory; Argonne IL 60439 USA
| | - Stefan Vogt
- Advanced Photon Source; X-ray Science Division; Argonne National Laboratory; Argonne IL 60439 USA
| | - David E. James
- Garvan Institute of Medical Research; 384 Victoria St Darlinghurst NSW 2010 Australia
- Charles Perkins Centre; The University of Sydney; NSW 2006 Australia
| | - Peter A. Lay
- School of Chemistry; The University of Sydney; NSW 2006 Australia
| |
Collapse
|
20
|
Wu S, Zhang X, Sun Y, Wu Z, Li T, Hu Y, Su D, Lv J, Li G, Zhang Z, Zheng L, Zhang J, Chen B. Transformation and Immobilization of Chromium by Arbuscular Mycorrhizal Fungi as Revealed by SEM-EDS, TEM-EDS, and XAFS. ENVIRONMENTAL SCIENCE & TECHNOLOGY 2015; 49:14036-14047. [PMID: 26551890 DOI: 10.1021/acs.est.5b03659] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Arbuscular mycorrhizal fungi (AMF), ubiquitous soil fungi that form symbiotic relationships with the majority of terrestrial plants, are known to play an important role in plant tolerance to chromium (Cr) contamination. However, the underlying mechanisms, especially the direct influences of AMF on the translocation and transformation of Cr in the soil-plant continuum, are still unresolved. In a two-compartment root-organ cultivation system, the extraradical mycelium (ERM) of mycorrhizal roots was treated with 0.05 mmol L(-1) Cr(VI) for 12 days to investigate the uptake, translocation, and transformation of Cr(VI) by AMF using inductively coupled plasma mass spectrometry (ICP-MS), scanning electron microscopy equipped with energy-dispersive spectroscopy (SEM-EDS), transmission electron microscopy equipped with energy-dispersive spectroscopy (TEM-EDS), and X-ray-absorption fine structure (XAFS) technologies. The results indicated that AMF can immobilize quantities of Cr via reduction of Cr(VI) to Cr(III), forming Cr(III)-phosphate analogues, likely on the fungal surface. Besides this, we also confirmed that the extraradical mycelium (ERM) can actively take up Cr [either in the form of Cr(VI) or Cr(III)] and transport Cr [potentially in the form of Cr(III)-histidine analogues] to mycorrhizal roots but immobilize most of the Cr(III) in the fungal structures. Based on an X-ray absorption near-edge spectroscopy analysis of Cr(VI)-treated roots, we proposed that the intraradical fungal structures can also immobilize Cr within mycorrhizal roots. Our findings confirmed the immobilization of Cr by AMF, which plays an essential role in the Cr(VI) tolerance of AM symbioses.
Collapse
Affiliation(s)
- Songlin Wu
- University of Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | | | - Yuqing Sun
- University of Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | - Zhaoxiang Wu
- University of Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | | | - Yajun Hu
- Key Laboratory of Agro-ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences , Changsha 410125, People's Republic of China
| | - Dan Su
- University of Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | | | | | | | - Lirong Zheng
- Beijing Synchrotron Radiation Facility, Institute of High Energy Physics, Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | - Jing Zhang
- Beijing Synchrotron Radiation Facility, Institute of High Energy Physics, Chinese Academy of Sciences , Beijing 100049, People's Republic of China
| | | |
Collapse
|
21
|
Levina A, McLeod AI, Gasparini SJ, Nguyen A, De Silva WGM, Aitken JB, Harris HH, Glover C, Johannessen B, Lay PA. Reactivity and Speciation of Anti-Diabetic Vanadium Complexes in Whole Blood and Its Components: The Important Role of Red Blood Cells. Inorg Chem 2015; 54:7753-66. [PMID: 26230577 DOI: 10.1021/acs.inorgchem.5b00665] [Citation(s) in RCA: 64] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Reactions with blood components are crucial for controlling the antidiabetic, anticancer, and other biological activities of V(V) and V(IV) complexes. Despite extensive studies of V(V) and V(IV) reactions with the major blood proteins (albumin and transferrin), reactions with whole blood and red blood cells (RBC) have been studied rarely. A detailed speciation study of Na3[V(V)O4] (A), K4[V(IV)2O2(citr)2]·6H2O (B; citr = citrato(4-)); [V(IV)O(ma)2] (C; ma = maltolato(-)), and (NH4)[V(V)(O)2(dipic)] (D; dipic = pyridine-2,6-dicarboxylato(2-)) in whole rat blood, freshly isolated rat plasma, and commercial bovine serum using X-ray absorption near-edge structure (XANES) spectroscopy is reported. The latter two compounds are potential oral antidiabetic drugs, and the former two are likely to represent their typical decomposition products in gastrointestinal media. XANES spectral speciation was performed by principal component analysis and multiple linear regression techniques, and the distribution of V between RBC and plasma fractions was measured by electrothermal atomic absorption spectroscopy. Reactions of A, C, or D with whole blood (1.0 mM V, 1-6 h at 310 K) led to accumulation of ∼50% of total V in the RBC fraction (∼10% in the case of B), which indicated that RBC act as V carriers to peripheral organs. The spectra of V products in RBC were independent of the initial V complex, and were best fitted by a combination of V(IV)-carbohydrate (2-hydroxyacid moieties) and/or citrate (65-85%) and V(V)-protein (15-35%) models. The presence of RBC created a more reducing environment in the plasma fraction of whole blood compared with those in isolated plasma or serum, as shown by the differences in distribution of V(IV) and V(V) species in the reaction products of A-D in these media. At physiologically relevant V concentrations (<50 μM), this role of RBC may promote the formation of V(III)-transferrin as a major V carrier in the blood plasma. The results reported herein have broad implications for the roles of RBC in the transport and speciation of metal pro-drugs that have broad applications across medicine.
Collapse
Affiliation(s)
- Aviva Levina
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| | - Andrew I McLeod
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| | - Sylvia J Gasparini
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| | - Annie Nguyen
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| | | | - Jade B Aitken
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia.,‡Australian Synchrotron, 800 Blackburn Rd., Clayton VIC 3168, Australia
| | - Hugh H Harris
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| | - Chris Glover
- ‡Australian Synchrotron, 800 Blackburn Rd., Clayton VIC 3168, Australia
| | - Bernt Johannessen
- ‡Australian Synchrotron, 800 Blackburn Rd., Clayton VIC 3168, Australia
| | - Peter A Lay
- †School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| |
Collapse
|
22
|
Levina A, McLeod AI, Pulte A, Aitken JB, Lay PA. Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study. Inorg Chem 2015; 54:6707-18. [PMID: 25906315 PMCID: PMC4511291 DOI: 10.1021/ic5028948] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
![]()
The antidiabetic activities of vanadium(V)
and -(IV) prodrugs are determined by their ability to release active
species upon interactions with components of biological media. The
first X-ray absorption spectroscopic study of the reactivity of typical
vanadium (V) antidiabetics, vanadate ([VVO4]3–, A) and a vanadium(IV) bis(maltolato)
complex (B), with mammalian cell cultures has been performed
using HepG2 (human hepatoma), A549 (human lung carcinoma), and 3T3-L1
(mouse adipocytes and preadipocytes) cell lines, as well as the corresponding
cell culture media. X-ray absorption near-edge structure data were
analyzed using empirical correlations with a library of model vanadium(V),
-(IV), and -(III) complexes. Both A and B ([V] = 1.0 mM) gradually converged into similar mixtures of predominantly
five- and six-coordinate VV species (∼75% total
V) in a cell culture medium within 24 h at 310 K. Speciation of V
in intact HepG2 cells also changed with the incubation time (from
∼20% to ∼70% VIV of total V), but it was
largely independent of the prodrug used (A or B) or of the predominant V oxidation state in the medium. Subcellular
fractionation of A549 cells suggested that VV reduction
to VIV occurred predominantly in the cytoplasm, while accumulation
of VV in the nucleus was likely to have been facilitated
by noncovalent bonding to histone proteins. The nuclear VV is likely to modulate the transcription process and to be ultimately
related to cell death at high concentrations of V, which may be important
in anticancer activities. Mature 3T3-L1 adipocytes (unlike for preadipocytes)
showed a higher propensity to form VIV species, despite
the prevalence of VV in the medium. The distinct V biochemistry
in these cells is consistent with their crucial role in insulin-dependent
glucose and fat metabolism and may also point to an endogenous role
of V in adipocytes. The first detailed
speciation study of typical antidiabetic vanadium(V/IV) complexes
in mammalian cell culture systems showed that the complexes decomposed
rapidly in cell culture media and were further metabolized by the
cells, which included interconversions of VV and VIV species.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Andrew I McLeod
- School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Anna Pulte
- School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Jade B Aitken
- School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Peter A Lay
- School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
23
|
Kremer LE, McLeod AI, Aitken JB, Levina A, Lay PA. Vanadium(V) and -(IV) complexes of anionic polysaccharides: Controlled release pharmaceutical formulations and models of vanadium biotransformation products. J Inorg Biochem 2015; 147:227-34. [PMID: 25958254 DOI: 10.1016/j.jinorgbio.2015.03.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2014] [Revised: 03/20/2015] [Accepted: 03/28/2015] [Indexed: 02/01/2023]
Abstract
Uncontrolled reactions in biological media are a main obstacle for clinical translation of V-based anti-diabetic or anti-cancer pro-drugs. We investigated the use of controlled-release pharmaceutical formulations to ameliorate this issue with a series of V(V) and (IV) complexes of anionic polysaccharides. Carboxymethyl cellulose, xanthan gum, or alginic acid formulations were prepared by the reactions of [VO4](3-) with one or two molar equivalents of biological reductants, L-ascorbic acid (AA) or L-cysteine (Cys), in the presence of excess polysaccharide at pH~7 or pH~4. XANES studies with the use of a previously developed library of model V(V), V(IV) and V(III) complexes showed that reactions in the presence of AA led mostly to the mixtures of five- and six-coordinate V(IV) species, while the reactions in the presence of Cys led predominantly to the mixtures of five- and six-coordinate V(V) species. The XANES spectra of some of these samples closely matched those reported previously for [VO4](3-) biotransformation products in isolated blood plasma, red blood cells, or cultured adipocytes, which supports the hypothesis that modified polysaccharides are major binders of V(V) and V(IV) in biological systems. Studies by EPR spectroscopy suggested predominant V(IV)-carboxylato binding in complexes with polysaccharides. One of the isolated products (a V(IV)-alginato complex) showed selective release of low-molecular-mass V species at pH~8, but not at pH~2, which makes it a promising lead for the development of V-containing formulations for oral administration that are stable in the stomach, but release the active ingredient in the intestines.
Collapse
Affiliation(s)
- Lauren E Kremer
- School of Chemistry The University of Sydney, Sydney, NSW 2006, Australia
| | - Andrew I McLeod
- School of Chemistry The University of Sydney, Sydney, NSW 2006, Australia
| | - Jade B Aitken
- School of Chemistry The University of Sydney, Sydney, NSW 2006, Australia
| | - Aviva Levina
- School of Chemistry The University of Sydney, Sydney, NSW 2006, Australia
| | - Peter A Lay
- School of Chemistry The University of Sydney, Sydney, NSW 2006, Australia.
| |
Collapse
|
24
|
Pham THN, Aitken JB, Levina A, Lay PA. Solid-State Structural Studies of Chromium(III) Nicotinato Nutritional Supplements. Inorg Chem 2014; 53:10685-94. [DOI: 10.1021/ic501818w] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- T. H. Nguyen Pham
- School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Jade B. Aitken
- School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
- Australian Synchrotron, Clayton, Victoria 3168, Australia
- Institute of Materials Structure Science, KEK, Tsukuba, Ibaraki 305-0801, Japan
| | - Aviva Levina
- School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Peter A. Lay
- School
of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
25
|
Levina A, McLeod AI, Kremer LE, Aitken JB, Glover CJ, Johannessen B, Lay PA. Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study. Metallomics 2014; 6:1880-8. [PMID: 25100248 DOI: 10.1039/c4mt00146j] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The reactions of oral V(V/IV) anti-diabetic drugs within the gastrointestinal environment (particularly in the presence of food) are a crucial factor that affects their biological activities, but to date these have been poorly understood. In order to build up reactivity-activity relationships, the first detailed study of the reactivities of typical V-based anti-diabetics, Na3V(V)O4 (A), [V(IV)O(OH2)5](SO4) (B), [V(IV)O(ma)2] (C, ma = maltolato(-)) and (NH4)[V(V)(O)2(dipic)] (D, dipic = pyridine-2,5-dicarboxylato(2-)) with simulated gastrointestinal (GI) media in the presence or absence of food components has been performed by the use of XANES (X-ray absorption near edge structure) spectroscopy. Changes in speciation under conditions that simulate interactions in the GI tract have been discerned using correlations of XANES parameters that were based on a library of model V(V), V(IV), and V(III) complexes for preliminary assessment of the oxidation states and coordination numbers. More detailed speciation analyses were performed using multiple linear regression fits of XANES from the model complexes to XANES obtained from the reaction products from interactions with the GI media. Compounds B and D were relatively stable in the gastric environment (pH ∼ 2) in the absence of food, while C was mostly dissociated, and A was converted to [V10O28](6-). Sequential gastric and intestinal digestion in the absence of food converted A, B and D to poorly absorbed tetrahedral vanadates, while C formed five- or six-coordinate V(V) species where the maltolato ligands were likely to be partially retained. XANES obtained from gastric digestion of A-D in the presence of typical food components converged to that of a mixture of V(IV)-aqua, V(IV)-amino acid and V(III)-aqua complexes. Subsequent intestinal digestion led predominantly to V(IV) complexes that were assigned as citrato or complexes with 2-hydroxyacidato donor groups from other organic compounds, including certain carbohydrates. The absence of strong reductants (such as ascorbate) in the food increased the V(V) component in gastrointestinal digestion products. These results can be used to predict the oral bioavailability of various types of V(V/IV) anti-diabetics, and the effects of taking such drugs with food.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| | | | | | | | | | | | | |
Collapse
|
26
|
Levina A, McLeod AI, Lay PA. Vanadium Speciation by XANES Spectroscopy: A Three-Dimensional Approach. Chemistry 2014; 20:12056-60. [DOI: 10.1002/chem.201403993] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2014] [Indexed: 11/09/2022]
|
27
|
Abstract
Chromium is ubiquitous in the environment as Cr(III) and Cr(VI) oxidation states, which interconvert under environmentally and biologically relevant conditions (although Cr(III) usually predominates). While Cr(VI) is an established human carcinogen and a major occupational and environmental hazard, Cr(III) has long been regarded as an essential human micronutrient, although recent literature has cast serious doubts on the validity of this postulate. Despite five decades of research, no functional Cr-containing enzymes or cofactors have been characterized conclusively, and several hypotheses on their possible structures have been refuted. Gastrointestinal absorption pathways for both Cr(III) and Cr(VI) are apparent and whole-blood speciation can involve Cr(VI) uptake and reduction by red blood cells, as well as Cr(III) binding to both proteins and low-molecular-mass ligands in the plasma. DNA-damaging effects of Cr(VI) and anti-diabetic activities of Cr(III) are likely to arise from common mechanistic pathways that involve reactive Cr(VI/V/IV) intermediates and kinetically inert Cr(III)-protein and Cr(III)-DNA adducts. Both Cr(III) and Cr(VI) are toxic to plants and microorganisms, particularly Cr(VI) due to its higher bioavailability and redox chemistry. Some bacteria reduce Cr(VI) to Cr(III) without the formation of toxic Cr(V) intermediates and these bacteria are being considered for use in the bioremediation of Cr(VI)-polluted environments.
Collapse
Affiliation(s)
- Peter A. Lay
- School of Chemistry, The University of Sydney Sydney NSW 2006 Australia
| | - Aviva Levina
- School of Chemistry, The University of Sydney Sydney NSW 2006 Australia
| |
Collapse
|
28
|
Bartholomäus R, Irwin JA, Shi L, Smith SM, Levina A, Lay PA. Isolation, Characterization, and Nuclease Activity of Biologically Relevant Chromium(V) Complexes with Monosaccharides and Model Diols. Likely Intermediates in Chromium-Induced Cancers. Inorg Chem 2013; 52:4282-92. [DOI: 10.1021/ic3022408] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Ruben Bartholomäus
- Fachbereich Chemie, Philipps-Universität Marburg,
Hans-Meerwein-Strasse, D-35032 Marburg, Germany
- School of Chemistry, The University of Sydney, New South
Wales 2006, Australia
| | - Jennifer A. Irwin
- School of Chemistry, The University of Sydney, New South
Wales 2006, Australia
| | - Liwei Shi
- School of Chemistry, The University of Sydney, New South
Wales 2006, Australia
| | - Siwaporn Meejoo Smith
- School of Chemistry, The University of Sydney, New South
Wales 2006, Australia
- Department of Chemistry, Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand
| | - Aviva Levina
- School of Chemistry, The University of Sydney, New South
Wales 2006, Australia
| | - Peter A. Lay
- School of Chemistry, The University of Sydney, New South
Wales 2006, Australia
| |
Collapse
|
29
|
Pacheco M, Santos MA, Pereira P, Martínez JI, Alonso PJ, Soares MJ, Lopes JC. EPR detection of paramagnetic chromium in liver of fish (Anguilla anguilla) treated with dichromate(VI) and associated oxidative stress responses-contribution to elucidation of toxicity mechanisms. Comp Biochem Physiol C Toxicol Pharmacol 2013; 157:132-40. [PMID: 23142145 DOI: 10.1016/j.cbpc.2012.10.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/30/2012] [Revised: 10/29/2012] [Accepted: 10/30/2012] [Indexed: 11/20/2022]
Abstract
The impact of chromium (Cr) on fish health has been the subject of numerous investigations, establishing a wide spectrum of toxicity, attributed particularly to the hexavalent form [Cr(VI)]. However, reports on the simultaneous assessment of Cr toxicity in fish and its toxico-kinetics, namely involving metal speciation, are scarce. Therefore, keeping in view the understanding of the mechanisms of Cr(VI) toxicity, this work intended to detect the formation of paramagnetic Cr species in liver of Anguilla anguilla following short-term dichromate(VI) intraperitoneal treatment (up to 180 min), assessing simultaneously the pro-oxidant properties. The formation of Cr(V) and Cr(III) was examined by electron paramagnetic resonance (EPR), as an innovative approach in the context of fish toxicology, and related with the levels of total Cr. Cr(V) was successfully detected and quantified by EPR spectrometry, showing a transient occurrence, mostly between 15 and 90 min post-injection, with a peak at 30 min. The limitations of EPR methodology towards the detection and quantification of Cr(III) were confirmed. Although Cr(VI) exposure induced the antioxidant system in the eel's liver, the oxidative deterioration of lipids was not prevented. Overall, the results suggested that Cr(V), as a short-lived species, did not appear to be directly and primarily responsible for the cellular damaging effects observed, since stress responses persisted up to the end of exposure regardless Cr(V) drastic decay. Though further research is needed, ROS mediated pathways (suggested by superoxide dismutase and catalase activity induction) and formation of Cr(III) complexes emerged as the most plausible mechanisms involved in Cr(VI) toxicity.
Collapse
Affiliation(s)
- M Pacheco
- Biology Department of the University of Aveiro & CESAM, 3810-193 Aveiro, Portugal.
| | | | | | | | | | | | | |
Collapse
|
30
|
Levina A, Aitken JB, Gwee YY, Lim ZJ, Liu M, Singharay AM, Wong PF, Lay PA. Biotransformations of anticancer ruthenium(III) complexes: an X-ray absorption spectroscopic study. Chemistry 2013; 19:3609-19. [PMID: 23361836 DOI: 10.1002/chem.201203127] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2012] [Indexed: 11/06/2022]
Abstract
An anti-metastatic drug, NAMI-A ((ImH)[Ru(III) Cl4 (Im)(dmso)]; Im=imidazole, dmso=S-bound dimethylsulfoxide), and a cytotoxic drug, KP1019 ((IndH)[Ru(III) Cl4 (Ind)2 ]; Ind=indazole), are two Ru-based anticancer drugs in human clinical trials. Their reactivities under biologically relevant conditions, including aqueous buffers, protein solutions or gels (e.g, albumin, transferrin and collagen), undiluted blood serum, cell-culture medium and human liver (HepG2) cancer cells, were studied by Ru K-edge X-ray absorption spectroscopy (XAS). These XAS data were fitted from linear combinations of spectra of well-characterised Ru compounds. The absence of XAS data from the parent drugs in these fits points to profound changes in the coordination environments of Ru(III) . The fits point to the presence of Ru(IV/III) clusters and binding of Ru(III) to S-donor groups, amine/imine and carboxylato groups of proteins. Cellular uptake of KP1019 is approximately 20-fold higher than that of NAMI-A under the same conditions, but it diminishes drastically after the decomposition of KP1019 in cell-culture media, which indicate that the parent complex is taken in by cells through passive diffusion.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Vincent JB, Love ST. The need for combined inorganic, biochemical, and nutritional studies of chromium(III). Chem Biodivers 2013; 9:1923-41. [PMID: 22976981 DOI: 10.1002/cbdv.201100440] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The history of biochemical and nutritional studies of the element is unfortunately full of twists and turns, most leading to dead ends. Chromium (Cr), as the trivalent ion, has been proposed to be an essential element, a body mass and muscle development agent, and, in the form of the most popular Cr-containing nutritional supplement, to be toxic when given orally to mammals. None of these proposals, despite significant attention in the popular media, has proven to be correct. Trivalent chromium has also been proposed as a therapeutic agent to increase insulin sensitivity and affect lipid metabolism, although a molecular mechanism for such actions has not been elucidated. Greater cooperative research interactions between nutritionists, biochemists, and chemists might have avoided the earlier issues in nutritional and biochemical Cr research and is necessary to establish the potential role of Cr as a therapeutic agent at a molecular level.
Collapse
Affiliation(s)
- John B Vincent
- Department of Chemistry, The University of Alabama, Tucaloosa, AL 35487-0336, USA.
| | | |
Collapse
|
32
|
Abstract
Over fifty years ago, the element chromium (as the trivalent ion) was proposed to be an essential element for mammals with a role in maintaining proper carbohydrate and lipid metabolism. Evidence for an essential role came from dietary studies with rodents, studies on the effects of chromium on subjects on total parenteral nutrition, and studies of the absorption and transport of chromium. Over the next several decades, chromium-containing nutritional supplements became so popular for weight loss and muscle development that sales were second only to calcium among mineral supplements. However, the failure to identify the responsible biomolecules(s) that bind chromium(III) and their mode of action, particularly a postulated species named glucose tolerance factor or GTF, resulted in the status of chromium being questioned in recent years, such that the question of its being essential needs to be formally readdressed. At the same time as chromium(III)'s popularity as a nutritional supplement was growing, concerns over its safety appeared. While chromium has been conclusively shown not to have beneficial effects on body mass or composition and should be removed from the list of essential trace elements, chromium(III) compounds are generally nontoxic and have beneficial pharmacological effects in rodents models of insulin insensitivity, although human studies have not conclusively shown any beneficial effects. Mechanisms have been proposed for these pharmacological effects, but all suffer from a lack of consistent supporting evidence.
Collapse
Affiliation(s)
- John B Vincent
- Department of Chemistry, University of Alabama, Tuscaloosa, AL, 35487-0336, USA,
| |
Collapse
|
33
|
George GN, Pickering IJ, Pushie MJ, Nienaber K, Hackett MJ, Ascone I, Hedman B, Hodgson KO, Aitken JB, Levina A, Glover C, Lay PA. X-ray-induced photo-chemistry and X-ray absorption spectroscopy of biological samples. JOURNAL OF SYNCHROTRON RADIATION 2012; 19:875-86. [PMID: 23093745 PMCID: PMC3480274 DOI: 10.1107/s090904951203943x] [Citation(s) in RCA: 104] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2012] [Accepted: 09/16/2012] [Indexed: 05/03/2023]
Abstract
As synchrotron light sources and optics deliver greater photon flux on samples, X-ray-induced photo-chemistry is increasingly encountered in X-ray absorption spectroscopy (XAS) experiments. The resulting problems are particularly pronounced for biological XAS experiments. This is because biological samples are very often quite dilute and therefore require signal averaging to achieve adequate signal-to-noise ratios, with correspondingly greater exposures to the X-ray beam. This paper reviews the origins of photo-reduction and photo-oxidation, the impact that they can have on active site structure, and the methods that can be used to provide relief from X-ray-induced photo-chemical artifacts.
Collapse
Affiliation(s)
- Graham N. George
- Department of Geological Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E2
| | - Ingrid J. Pickering
- Department of Geological Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E2
| | - M. Jake Pushie
- Department of Geological Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E2
| | - Kurt Nienaber
- Department of Geological Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E2
| | - Mark J. Hackett
- Department of Geological Sciences, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E2
| | - Isabella Ascone
- ENSCP Chimie ParisTech, LCF, CNRS, UMR 7223, 75005 Paris, France
| | - Britt Hedman
- Department of Chemistry, Stanford University, Stanford, CA 94305, USA
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - Keith O. Hodgson
- Department of Chemistry, Stanford University, Stanford, CA 94305, USA
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - Jade B. Aitken
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
- Australian Synchrotron, Clayton, VIC 3168, Australia
- Institute of Materials Structure Science, KEK, Tsukuba, Ibaraki 305-0801, Japan
| | - Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | | | - Peter A. Lay
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
34
|
Structural approaches to probing metal interaction with proteins. J Inorg Biochem 2012; 115:138-47. [DOI: 10.1016/j.jinorgbio.2012.02.015] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2011] [Revised: 02/02/2012] [Accepted: 02/20/2012] [Indexed: 12/13/2022]
|
35
|
Dillon CT. Synchrotron Radiation Spectroscopic Techniques as Tools for the Medicinal Chemist: Microprobe X-Ray Fluorescence Imaging, X-Ray Absorption Spectroscopy, and Infrared Microspectroscopy. Aust J Chem 2012. [DOI: 10.1071/ch11287] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
This review updates the recent advances and applications of three prominent synchrotron radiation techniques, microprobe X-ray fluorescence spectroscopy/imaging, X-ray absorption spectroscopy, and infrared microspectroscopy, and highlights how these tools are useful to the medicinal chemist. A brief description of the principles of the techniques is given with emphasis on the advantages of using synchrotron radiation-based instrumentation rather than instruments using typical laboratory radiation sources. This review focuses on several recent applications of these techniques to solve inorganic medicinal chemistry problems, focusing on studies of cellular uptake, distribution, and biotransformation of established and potential therapeutic agents. The importance of using these synchrotron-based techniques to assist the development of, or validate the chemistry behind, drug design is discussed.
Collapse
|
36
|
Aitken JB, Antony S, Weekley CM, Lai B, Spiccia L, Harris HH. Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells. Metallomics 2012; 4:1051-6, 1007. [DOI: 10.1039/c2mt20072d] [Citation(s) in RCA: 85] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
37
|
Abstract
Drinking water supplies in many geographic areas contain chromium in the +3 and +6 oxidation states. Public health concerns are centered on the presence of hexavalent Cr that is classified as a known human carcinogen via inhalation. Cr(VI) has high environmental mobility and can originate from anthropogenic and natural sources. Acidic environments with high organic content promote the reduction of Cr(VI) to nontoxic Cr(III). The opposite process of Cr(VI) formation from Cr(III) also occurs, particularly in the presence of common minerals containing Mn(IV) oxides. Limited epidemiological evidence for Cr(VI) ingestion is suggestive of elevated risks for stomach cancers. Exposure of animals to Cr(VI) in drinking water induced tumors in the alimentary tract, with linear and supralinear responses in the mouse small intestine. Chromate, the predominant form of Cr(VI) at neutral pH, is taken up by all cells through sulfate channels and is activated nonenzymatically by ubiquitously present ascorbate and small thiols. The most abundant form of DNA damage induced by Cr(VI) is Cr-DNA adducts, which cause mutations and chromosomal breaks. Emerging evidence points to two-way interactions between DNA damage and epigenetic changes that collectively determine the spectrum of genomic rearrangements and profiles of gene expression in tumors. Extensive formation of DNA adducts, clear positivity in genotoxicity assays with high predictive values for carcinogenicity, the shape of tumor-dose responses in mice, and a biological signature of mutagenic carcinogens (multispecies, multisite, and trans-sex tumorigenic potency) strongly support the importance of the DNA-reactive mutagenic mechanisms in carcinogenic effects of Cr(VI). Bioavailability results and kinetic considerations suggest that 10-20% of ingested low-dose Cr(VI) escapes human gastric inactivation. The directly mutagenic mode of action and the incompleteness of gastric detoxification argue against a threshold in low-dose extrapolation of cancer risk for ingested Cr(VI).
Collapse
Affiliation(s)
- Anatoly Zhitkovich
- Department of Pathology and Laboratory Medicine, Brown University, 70 Ship Street, Providence, RI 02912, United States.
| |
Collapse
|
38
|
Abstract
The current status and likely future directions of complexes of V(V/IV), Cr(III), Mo(VI), W(VI), Zn(II), Cu(II), and Mn(III) as potential oral drugs against type 2 diabetes are reviewed. We propose a unified model of extra- and intracellular mechanisms of anti-diabetic efficacies of V(V/IV), Mo(VI), W(VI), and Cr(III), centred on high-oxidation-state oxido/peroxido species that inhibit protein tyrosine phosphatases (PTPs) involved in insulin signalling. The postulated oxidative mechanism of anti-diabetic activity of Cr(III) via carcinogenic Cr(VI/V) (which adds to safety concerns) is consistent with recent clinical trials on Cr(III) picolinate, where activity was apparent only in patients with poorly controlled diabetes (high oxidative stress), and the correlation between the anti-diabetic activities and ease of oxidation of Cr(III) supplements and their metabolites in vivo. Zn(II) and Cu(II) anti-diabetics act via different mechanisms and are unlikely to be used as specific anti-diabetics due to their diverse and unpredictable biological activities. Hence, future research directions are likely to centre on enhancing the bioavailability and selectivity of V(V/IV), Mo(VI), or W(VI) drugs. The strategy of potentiating circulating insulin with metal ions has distinct therapeutic advantages over interventions that stimulate the release of more insulin, or use insulin mimetics, because of many adverse side-effects of increased levels of insulin, including increased risks of cancer and cardiovascular diseases.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, NSW, Australia
| | | |
Collapse
|
39
|
Gómez-Ariza JL, Jahromi EZ, González-Fernández M, García-Barrera T, Gailer J. Liquid chromatography-inductively coupled plasma-based metallomic approaches to probe health-relevant interactions between xenobiotics and mammalian organisms. Metallomics 2011; 3:566-77. [PMID: 21614343 DOI: 10.1039/c1mt00037c] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
In mammals, the transport of essential elements from the gastrointestinal tract to organs is orchestrated by biochemical mechanisms which have evolved over millions of years. The subsequent organ-based assembly of sufficient amounts of metalloproteins is a prerequisite to maintain mammalian health and well-being. The chronic exposure of various human populations to environmentally abundant toxic metals/metalloid compounds and/or the deliberate administration of medicinal drugs, however, can adversely affect these processes which may eventually result in disease. A better understanding of the perturbation of these processes has the potential to advance human health, but their visualization poses a major problem. Nonetheless, liquid chromatography-inductively coupled plasma-based 'metallomics' methods, however, can provide much needed insight. Size-exclusion chromatography-inductively coupled plasma atomic emission spectrometry, for example, can be used to visualize changes that toxic metals/medicinal drugs exert at the metalloprotein level when they are added to plasma in vitro. In addition, size-exclusion chromatography-inductively coupled plasma mass spectrometry can be employed to analyze organs from toxic metal/medicinal drug-exposed organisms for metalloproteins to gain insight into the biochemical changes that are associated with their acute or chronic toxicity. The execution of such studies-from the selection of an appropriate model organism to the generation of accurate analytical data-is littered with potential pitfalls that may result in artifacts. Drawing on recent lessons that were learned by two research groups, this tutorial review is intended to provide relevant information with regard to the experimental design and the practical application of these aforementioned metallomics tools in applied health research.
Collapse
Affiliation(s)
- José Luis Gómez-Ariza
- Department of Chemistry and Material Sciences, Faculty of Experimental Science, University of Huelva, Campus de El Carmen, 21007 Huelva, Spain
| | | | | | | | | |
Collapse
|
40
|
Wedlock LE, Kilburn MR, Cliff JB, Filgueira L, Saunders M, Berners-Price SJ. Visualising gold inside tumour cells following treatment with an antitumour gold(i) complex. Metallomics 2011; 3:917-25. [DOI: 10.1039/c1mt00053e] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
41
|
Diacomanolis V, Ng JC, Sadler R, Nomura M, Noller BN, Harris HH. Consistent chemical form of Cd in liver and kidney tissues in rats dosed with a range of Cd treatments: XAS of intact tissues. Chem Res Toxicol 2010; 23:1647-9. [PMID: 21038871 DOI: 10.1021/tx100333r] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
X-ray absorption spectroscopy of frozen intact tissues shows that in rats exposed to a range of treatments involving cadmium, alone or in combination with other metal ions, the coordination environment of cadmium is consistent in both the liver and kidney. Comparison of the spectra from the rat tissues to biologically relevant model compounds indicates that the vast majority of the cadmium is bound to metallothionein in these tissues.
Collapse
Affiliation(s)
- Violet Diacomanolis
- The University of Queensland, National Research Centre for Environmental Toxicology-EnTox, Coopers Plains, QLD, Australia
| | | | | | | | | | | |
Collapse
|
42
|
Levina A, Zhang L, Lay PA. Formation and reactivity of chromium(V)-thiolato complexes: a model for the intracellular reactions of carcinogenic chromium(VI) with biological thiols. J Am Chem Soc 2010; 132:8720-31. [PMID: 20527748 DOI: 10.1021/ja101675w] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The nature of the long-lived EPR-active Cr(V) species observed in cells and biological fluids exposed to carcinogenic Cr(VI) has been definitively assigned from detailed kinetic and spectroscopic analyses of a model reaction of Cr(VI) with p-bromobenzenethiol (RSH) in the presence or absence of cyclic 1,2-diols (LH(2)) in aprotic or mixed solvents. The first definitive structures for Cr(V) complexes with a monodentate thiolato ligand, [Cr(V)O(SR)(4)](-) (g(iso) = 1.9960, A(iso) = 14.7 x 10(-4) cm(-1)), [Cr(V)OL(SR)(2)](-) (g(iso) = 1.9854, A(iso) = (15.8-16.2) x 10(-4) cm(-1)) and [Cr(V)(O)(2)(SR)(2)](-) (g(iso) = 1.9828, A(iso) = 6.8 x 10(-4) cm(-1)) were assigned by EPR spectroscopy and electrospray mass spectrometry. The unusually low A(iso) ((53)Cr) value for the latter species is consistent with its rare four-coordinate, bis-oxido structure. The [Cr(V)OL(SR)(2)](-) species are responsible for the transient g(iso) approximately 1.986 EPR signals observed in living cells and animals treated with Cr(VI) (where RSH and LH(2) are biological thiols and 1,2-diols, respectively). For the first time, concentrations of Cr(V) intermediates formed during the reduction of Cr(VI) were determined by quantitative EPR spectroscopy, and a detailed reaction mechanism was proposed on the basis of stochastic simulations of the kinetic curves for Cr(V) species. A key feature of the proposed mechanism is the regeneration of Cr(V) species in the presence of Cr(VI) through the formation of organic free radicals, followed by the rapid reactions of the formed radicals with Cr(VI). The concentration of Cr(V) grows rapidly at the beginning of the reaction, reaches a steady-state level, and then drops sharply once Cr(VI) is spent. Similar mechanisms are likely to operate during the reduction of Cr(VI) in biological environment rich in reactive C-H bonds, including the oxidative DNA damage by Cr(V) intermediates.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia
| | | | | |
Collapse
|
43
|
Finney L, Chishti Y, Khare T, Giometti C, Levina A, Lay PA, Vogt S. Imaging metals in proteins by combining electrophoresis with rapid x-ray fluorescence mapping. ACS Chem Biol 2010; 5:577-87. [PMID: 20392082 DOI: 10.1021/cb1000263] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Growing evidence points toward a very dynamic role for metals in biology. This suggests that physiological circumstance may mandate metal ion redistribution among ligands. This work addresses a critical need for technology that detects, identifies, and measures the metal-containing components of complex biological matrixes. We describe a direct, user-friendly approach for identifying and quantifying metal-protein adducts in complex samples using native- or SDS-PAGE, blotting, and rapid synchrotron X-ray fluorescence mapping with micro-XANES (X-ray absorption near-edge structure) of entire blots. The identification and quantification of each metal bound to a protein spot has been demonstrated, and the technique has been applied in two exemplary cases. In the first, the speciation of the in vitro binding of exogenous chromium to blood serum proteins was influenced markedly by both the oxidation state of chromium exposed to the serum proteins and the treatment conditions, which is of relevance to the biochemistry of Cr dietary supplements. In the second case, in vivo changes in endogenous metal speciation were examined to probe the influence of oxygen depletion on iron speciation in Shewanella oneidensis.
Collapse
Affiliation(s)
- Lydia Finney
- Biosciences Division and
- X-ray Sciences Division, Argonne National Laboratory, Argonne, Illinois
| | | | | | | | - Aviva Levina
- School of Chemistry, The University of Sydney, NSW 2006, Australia
| | - Peter A Lay
- School of Chemistry, The University of Sydney, NSW 2006, Australia
| | - Stefan Vogt
- X-ray Sciences Division, Argonne National Laboratory, Argonne, Illinois
| |
Collapse
|
44
|
Liu M, Lim ZJ, Gwee YY, Levina A, Lay PA. Characterization of a ruthenium(III)/NAMI-A adduct with bovine serum albumin that exhibits a high anti-metastatic activity. Angew Chem Int Ed Engl 2010; 49:1661-4. [PMID: 20127775 DOI: 10.1002/anie.200906079] [Citation(s) in RCA: 105] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Mimi Liu
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | | | | | | | | |
Collapse
|
45
|
Aitken JB, Carter EA, Eastgate H, Hackett MJ, Harris HH, Levina A, Lee YC, Chen CI, Lai B, Vogt S, Lay PA. Biomedical applications of X-ray absorption and vibrational spectroscopic microscopies in obtaining structural information from complex systems. Radiat Phys Chem Oxf Engl 1993 2010. [DOI: 10.1016/j.radphyschem.2009.03.068] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
46
|
Liu M, Lim Z, Gwee Y, Levina A, Lay P. Characterization of a Ruthenium(III)/NAMI-A Adduct with Bovine Serum Albumin that Exhibits a High Anti-Metastatic Activity. Angew Chem Int Ed Engl 2010. [DOI: 10.1002/ange.200906079] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
47
|
Abstract
Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH(+))[Ru(III)Cl(4)(Im)(S-dmso)], where Im = imidazole and S-dmso = S-bound dimethylsulfoxide) or KP1019 ((IndH(+))[Ru(III)Cl(4)(Ind)(2)], where Ind = indazole) have successfully completed phase I clinical trials and an array of other Ru complexes have shown promise for future development. Herein, the recent literature is reviewed critically to ascertain likely mechanisms of action of Ru-based anticancer drugs, with the emphasis on their reactions with biological media. The most likely interactions of Ru complexes are with: (i) albumin and transferrin in blood plasma, the former serving as a Ru depot, and the latter possibly providing active transport of Ru into cells; (ii) collagens of the extracellular matrix and actins on the cell surface, which are likely to be involved in the specific anti-metastatic action of Ru complexes; (iii) regulatory enzymes within the cell membrane and/or in the cytoplasm; and (iv) DNA in the cell nucleus. Some types of Ru complexes can also promote the intracellular formation of free radical species, either through irradiation (photodynamic therapy), or through reactions with cellular reductants. The metabolic pathways involve competition among reduction, aquation, and hydrolysis in the extracellular medium; binding to transport proteins, the extracellular matrix, and cell-surface biomolecules; and diffusion into cells; with the extent to which individual drugs participate in various steps along these pathways being crucial factors in determining whether they are mainly anti-metastatic or cytotoxic. This diversity of modes of action of Ru anticancer drugs is also likely to enhance their anticancer activities and to reduce the potential for them to develop tumour resistance. New approaches to metabolic studies, such as X-ray absorption spectroscopy and X-ray fluorescence microscopy, are required to provide further mechanistic insights, which could lead to the rational design of improved Ru anticancer drugs.
Collapse
Affiliation(s)
- Aviva Levina
- School of Chemistry, The University of Sydney, Sydney NSW 2006, Australia
| | | | | |
Collapse
|
48
|
|
49
|
Isolation and Characterization of Low-Molecular-Weight Chromium-binding Substance (LMWCr) from Chicken Liver. Protein J 2008; 27:371-5. [DOI: 10.1007/s10930-008-9146-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Nguyen A, Mulyani I, Levina A, Lay PA. Reactivity of Chromium(III) Nutritional Supplements in Biological Media: An X-Ray Absorption Spectroscopic Study. Inorg Chem 2008; 47:4299-309. [DOI: 10.1021/ic7024389] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Annie Nguyen
- School of Chemistry, The University of Sydney, NSW, 2006, Australia
| | - Irma Mulyani
- School of Chemistry, The University of Sydney, NSW, 2006, Australia
| | - Aviva Levina
- School of Chemistry, The University of Sydney, NSW, 2006, Australia
| | - Peter A. Lay
- School of Chemistry, The University of Sydney, NSW, 2006, Australia
| |
Collapse
|